{"count": 7, "results": [{"_id": "34505282", "pmid": 34505282, "pmcid": "PMC7612651", "title": "Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance", "journal": "J Physiol", "authors": ["Hufnagel A", "Fernandez-Twinn DS", "Blackmore HL", "Ashmore TJ", "Heaton RA", "Jenkins B", "Koulman A", "Hargreaves IP", "Aiken CE", "Ozanne SE"], "date": "2022-02-01T00:00:00Z", "doi": "10.1113/JP281902", "meta_date_publication": "2022 Feb", "meta_volume": "600", "meta_issue": "4", "meta_pages": "903-919", "score": 50271.43, "text_hl": "@<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@Maternal@@@ but not fetoplacental health can be improved by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in a @SPECIES_10090 @@@murine@@@ diet-induced model of @<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@maternal@@@ @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and @DISEASE_Glucose_Intolerance @DISEASE_MESH:D018149 @@@glucose intolerance@@@", "citations": {"NLM": "Hufnagel A, Fernandez-Twinn DS, Blackmore HL, Ashmore TJ, Heaton RA, Jenkins B, Koulman A, Hargreaves IP, Aiken CE, Ozanne SE. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance J Physiol. 2022 Feb;600(4):903-919. PMID: 34505282", "BibTeX": "@article{34505282, title={Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance}, author={Hufnagel A and Fernandez-Twinn DS and Blackmore HL and Ashmore TJ and Heaton RA and Jenkins B and Koulman A and Hargreaves IP and Aiken CE and Ozanne SE}, journal={J Physiol}, volume={600}, number={4}, pages={903-919}}"}}, {"_id": "36381747", "pmid": 36381747, "pmcid": "PMC9637404", "title": "A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes", "journal": "Cureus", "authors": ["Verma V", "Mehendale AM"], "date": "2022-10-07T00:00:00Z", "doi": "10.7759/cureus.30039", "meta_date_publication": "2022 Oct", "meta_volume": "14", "meta_issue": "10", "meta_pages": "e30039", "score": 50259.465, "text_hl": "A Review on the Use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Pregnancy and Its Associated Fetal Outcomes", "citations": {"NLM": "Verma V, Mehendale AM. A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes Cureus. 2022 Oct;14(10):e30039. PMID: 36381747", "BibTeX": "@article{36381747, title={A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes}, author={Verma V and Mehendale AM}, journal={Cureus}, volume={14}, number={10}, pages={e30039}}"}}, {"_id": "35621312", "pmid": 35621312, "title": "Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials.", "journal": "Gynecol Endocrinol", "authors": ["Zhao Q", "He J"], "date": "2022-07-01T00:00:00Z", "doi": "10.1080/09513590.2022.2080194", "meta_date_publication": "2022 Jul", "meta_volume": "38", "meta_issue": "7", "meta_pages": "558-568", "score": 50249.62, "text_hl": "CONCLUSIONS: The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in pregnant @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ can significantly reduce @<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@maternal@@@ complications. ", "citations": {"NLM": "Zhao Q, He J. Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials. Gynecol Endocrinol. 2022 Jul;38(7):558-568. PMID: 35621312", "BibTeX": "@article{35621312, title={Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials.}, author={Zhao Q and He J}, journal={Gynecol Endocrinol}, volume={38}, number={7}, pages={558-568}}"}}, {"_id": "35123389", "pmid": 35123389, "pmcid": "PMC8818203", "title": "Elevated RIF1 participates in the epigenetic abnormalities of zygotes by regulating histone modifications on MuERV-L in obese mice", "journal": "Mol Med", "authors": ["Huang J", "Ru G", "Sun J", "Sun L", "Li Z"], "date": "2022-02-05T00:00:00Z", "doi": "10.1186/s10020-022-00446-z", "meta_date_publication": "2022 Feb 5", "meta_volume": "28", "meta_issue": "1", "meta_pages": "17", "score": 50245.867, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ intervention experiments", "citations": {"NLM": "Huang J, Ru G, Sun J, Sun L, Li Z. Elevated RIF1 participates in the epigenetic abnormalities of zygotes by regulating histone modifications on MuERV-L in obese mice Mol Med. 2022 Feb 5;28(1):17. PMID: 35123389", "BibTeX": "@article{35123389, title={Elevated RIF1 participates in the epigenetic abnormalities of zygotes by regulating histone modifications on MuERV-L in obese mice}, author={Huang J and Ru G and Sun J and Sun L and Li Z}, journal={Mol Med}, volume={28}, number={1}, pages={17}}"}}, {"_id": "30528218", "pmid": 30528218, "title": "Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial.", "journal": "Lancet Diabetes Endocrinol", "authors": ["Dodd JM", "Louise J", "Deussen AR", "Grivell RM", "Dekker G", "McPhee AJ", "Hague W"], "date": "2019-01-01T00:00:00Z", "doi": "10.1016/S2213-8587(18)30310-3", "meta_date_publication": "2019 Jan", "meta_volume": "7", "meta_issue": "1", "meta_pages": "15-24", "score": 50054.28, "text_hl": "We aimed to assess the effects on @<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@maternal@@@ and infant outcomes of antenatal @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ given in addition to dietary and lifestyle advice among @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ and @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ pregnant @SPECIES_9606 @@@women@@@. ", "citations": {"NLM": "Dodd JM, Louise J, Deussen AR, Grivell RM, Dekker G, McPhee AJ, Hague W. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019 Jan;7(1):15-24. PMID: 30528218", "BibTeX": "@article{30528218, title={Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial.}, author={Dodd JM and Louise J and Deussen AR and Grivell RM and Dekker G and McPhee AJ and Hague W}, journal={Lancet Diabetes Endocrinol}, volume={7}, number={1}, pages={15-24}}"}}, {"_id": "26165398", "pmid": 26165398, "pmcid": "PMC4673088", "title": "Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial", "journal": "Lancet Diabetes Endocrinol", "authors": ["Chiswick C", "Reynolds RM", "Denison F", "Drake AJ", "Forbes S", "Newby DE", "Walker BR", "Quenby S", "Wray S", "Weeks A", "Lashen H", "Rodriguez A", "Murray G", "Whyte S", "Norman JE"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/S2213-8587(15)00219-3", "meta_date_publication": "2015 Oct", "meta_volume": "3", "meta_issue": "10", "meta_pages": "778-86", "score": 50053.73, "text_hl": "We aimed to establish whether the @GENE_INS @GENE_3630 @@@insulin@@@ sensitising drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ improves @<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@maternal@@@ and fetal outcomes in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ pregnant @SPECIES_9606 @@@women@@@ without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Chiswick C, Reynolds RM, Denison F, Drake AJ, Forbes S, Newby DE, Walker BR, Quenby S, Wray S, Weeks A, Lashen H, Rodriguez A, Murray G, Whyte S, Norman JE. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol. 2015 Oct;3(10):778-86. PMID: 26165398", "BibTeX": "@article{26165398, title={Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial}, author={Chiswick C and Reynolds RM and Denison F and Drake AJ and Forbes S and Newby DE and Walker BR and Quenby S and Wray S and Weeks A and Lashen H and Rodriguez A and Murray G and Whyte S and Norman JE}, journal={Lancet Diabetes Endocrinol}, volume={3}, number={10}, pages={778-86}}"}}, {"_id": "24528229", "pmid": 24528229, "title": "The use of oral hypoglycaemic agents in pregnancy.", "journal": "Diabet Med", "authors": ["Holt RI", "Lambert KD"], "date": "2014-03-01T00:00:00Z", "doi": "10.1111/dme.12376", "meta_date_publication": "2014 Mar", "meta_volume": "31", "meta_issue": "3", "meta_pages": "282-91", "score": 50044.22, "text_hl": "Studies of the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational diabetes@@@ show at least equivalent neonatal outcomes, while reporting reductions in @DISEASE_Infant_Newborn_Diseases @DISEASE_MESH:D007232 @@@neonatal hypoglycaemia@@@, @<m>DISEASE_Obesity_Maternal</m> @DISEASE_MESH:D000079262 @@@maternal hypoglycaemia@@@ and @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and improved treatment satisfaction. ", "citations": {"NLM": "Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med. 2014 Mar;31(3):282-91. PMID: 24528229", "BibTeX": "@article{24528229, title={The use of oral hypoglycaemic agents in pregnancy.}, author={Holt RI and Lambert KD}, journal={Diabet Med}, volume={31}, number={3}, pages={282-91}}"}}]}